MedPath

The Effect of Phosphatidylserine on Time Trial Performance in Trained Male Cyclists

Not Applicable
Conditions
The Focus of the Study is to Investigate the Effects of Phosphatidylserine Supplementation on Exercise Physiology and Cycling Time-trial Performance
Interventions
Dietary Supplement: Phosphatidylserine
Registration Number
NCT04967404
Lead Sponsor
Mark Glaister
Brief Summary

Phosphatidylserine is a phospholipid found in high concentrations in the brain and nervous tissues along with naturally occurring in many foods. It has been extensively studied for its effects on improving cognitive function, learning, memory and alleviating stress. However, more recently it has been proposed that phosphatidylserine could improve exercise capacity. The mechanisms of proposed action are difficult to distinguish because of the limited research and therefore the purpose of this study is to identify the proposed mechanism of action of phosphatidylserine supplementation and to establish whether these mechanisms will have an effect on time trial performance in trained male cyclists.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
20
Inclusion Criteria
  • Cyclists
  • Maximum oxygen uptake of at least 55 mL/kg/min
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Maltodextrin, 800 mg per day, 10 daysPhosphatidylserine-
Phosphatidylserine, 800 mg per day, 10 daysPhosphatidylserine-
Primary Outcome Measures
NameTimeMethod
30 minute cycling time-trial power output on an electromagnetically-braked cycle ergometerFrom baseline to 11 days post supplementation

Mean power output

Secondary Outcome Measures
NameTimeMethod
Rating of perceived exertion at four different exercise intensities (40, 50, 60 and 70% percent of maximal oxygen uptake) on an electromagnetically-braked cycle ergometerFrom baseline to 11 days post supplementation

Evaluated using a 15-point (6-20) scale

Oxygen consumption at four different exercise intensities (40, 50, 60 and 70% percent of maximal oxygen uptake) on an electromagnetically-braked cycle ergometerFrom baseline to 11 days post supplementation

Evaluated using an online breath-by-breath gas analyser

Breathing frequency at four different exercise intensities (40, 50, 60 and 70% percent of maximal oxygen uptake) on an electromagnetically-braked cycle ergometerFrom baseline to 11 days post supplementation

Evaluated using an online breath-by-breath gas analyser

Blood glucose concentration at four different exercise intensities (40, 50, 60 and 70% percent of maximal oxygen uptake) on an electromagnetically-braked cycle ergometerFrom baseline to 11 days post supplementation

Obtained via capillary puncture and analysed using an automated analyser

Minute ventilation at four different exercise intensities (40, 50, 60 and 70% percent of maximal oxygen uptake) on an electromagnetically-braked cycle ergometerFrom baseline to 11 days post supplementation

Evaluated using an online breath-by-breath gas analyser

Blood lactate concentration at four different exercise intensities (40, 50, 60 and 70% percent of maximal oxygen uptake) on an electromagnetically-braked cycle ergometerFrom baseline to 11 days post supplementation

Obtained via capillary puncture and analysed using an automated analyser

Heart rate at four different exercise intensities (40, 50, 60 and 70% percent of maximal oxygen uptake) on an electromagnetically-braked cycle ergometerFrom baseline to 11 days post supplementation

Evaluated using a heart rate monitor

Respiratory exchange ratio at four different exercise intensities (40, 50, 60 and 70% percent of maximal oxygen uptake) on an electromagnetically-braked cycle ergometerFrom baseline to 11 days post supplementation

Evaluated using an online breath-by-breath gas analyser

© Copyright 2025. All Rights Reserved by MedPath